Article

Congress passes legislation regarding military members with eye trauma

Washington, DC-Congress has approved legislation to improve the Department of Defense's (DoD) and the Veterans Health Administrations' (VHA) ability to treat those who have incurred serious eye injures while on active duty.

Washington, DC-Congress has approved legislation to improve the Department of Defense's (DoD) and the Veterans Health Administrations' (VHA) ability to treat those who have incurred serious eye injures while on active duty.

Also, as a part of the National Defense Authorization Act, a center of excellence will be established within the DoD to improve the tracking, diagnosis, treatment, and follow-up for service members who already have had severe eye injuries.

The measure is expected signed by President Bush as soon as today.

Joined with the Blinded Veterans Association and other veterans' service organizations, the American Academy of Ophthalmology (AAO) expressed support of the legislation, which also will create a formal registry housing electronic records, enabling the DoD and Department of Veterans Affairs (VA) to share patient information.

"We want to ensure that active duty members and veterans of prior service are provided with excellent eye care and resources," said James C. Orcutt, MD, PhD, chief ophthalmology consultant for the VHA and a member of the AAO. "The establishment of a registry that will allow us to track veterans and active duty personnel who have eye injuries significantly enhances our ability to meet that goal. In addition, the ability of the DoD and VA to work hand in hand on eye injury cases will benefit both active duty troops and veterans."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.